Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: miR-101-3p and Autotaxin in SLE Patients

View source ↗

Summary

This document reports a clinical study evaluating the roles of miR-101-3p and autotaxin in patients with Systemic Lupus Erythematosus, with the trial not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eman Mohamed Shawky | Conditions: Systemic Lupus Erythematosus (SLE) | Status: NOT_YET_RECRUITING